Skip to Primary Navigation

UK MHRA announces shift in AI healthcare strategy

UK hospital lab
Photo: Dan Kitwood/Getty Images

Initial phase will see AI tools deployed in live clinical settings.

A deliberate shift in how the UK intends to govern AI in healthcare has been signaled by the publication of a report by the Medicines and Healthcare products Regulatory Agency (MHRA).

The focus is on AI tools for medicine safety and development and how AI-enabled medical devices can be deployed

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience